Renu Virmani

ORCID: 0000-0003-1879-0015
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Peripheral Artery Disease Management
  • Atherosclerosis and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Aortic aneurysm repair treatments
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Structural Anomalies and Repair
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Effects of Exercise
  • Angiogenesis and VEGF in Cancer
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Health and Disease Prevention
  • Acute Ischemic Stroke Management
  • Cardiac tumors and thrombi
  • Cell Adhesion Molecules Research
  • Vascular Procedures and Complications
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Aortic Thrombus and Embolism
  • Protease and Inhibitor Mechanisms
  • Venous Thromboembolism Diagnosis and Management

CVPath Institute
2016-2025

Johns Hopkins University
1989-2024

University of Maryland, Baltimore
2002-2024

Icahn School of Medicine at Mount Sinai
2011-2023

University of British Columbia
2004-2022

Houston Methodist
2017-2022

Yale University
2022

Abbott Vascular (United States)
2009-2021

Terumo (Germany)
2009-2021

OrbusNeich (China)
2010-2021

Kristian Thygesen Joseph S. Alpert Allan S. Jaffe Bernard R. Chaitman Jeroen J. Bax and 95 more David A. Morrow Harvey D. White Kristian Thygesen Joseph S. Alpert Allan S. Jaffe Bernard R. Chaitman Jeroen J. Bax David A. Morrow Harvey D. White Hans Mickley Filippo Crea Frans Van de Werf Chiara Bucciarelli‐Ducci Hugo A. Katus Fausto J. Pinto Elliott M. Antman Christian W. Hamm Raffaele De Caterina James L. Januzzi Fred S. Apple María Ángeles Alonso García S. Richard Underwood John M. Canty Alexander R. Lyon P.J. Devereaux José Luis Zamorano Bertil Lindahl William S. Weintraub L. Kristin Newby Renu Virmani Pascal Vranckx Don Cutlip Raymond J. Gibbons Sidney C. Smith Dan Atar Russell V. Luepker Rose Marie Robertson Robert O. Bonow Philippe Gabríel Steg Patrick T. O’Gara Keith A.A. Fox David Hasdai Victor Aboyans Stephan Achenbach Stefan Agewall Thomas Alexander Álvaro Avezum Emanuele Barbato Jean‐Pierre Bassand Eric Bates John A. Bittl Güenter Breithardt Héctor Bueno Raffaele Bugiardini Mauricio G. Cohen George Dangas James A. de Lemos Victoria Delgado Gerasimos Filippatos Edward T.A. Fry Christopher B. Granger Sigrun Halvorsen Mark A. Hlatky Borja Ibáñez Stefan James Adnan Kastrati Christophe Leclercq Kenneth W. Mahaffey Laxmi S. Mehta Christian Müller Carlo Patrono Massimo Piepoli Daniel Piñeiro Marco Roffi Andrea Rubboli Samin K. Sharma Iain A. Simpson Michał Tendera Marco Valgimigli Allard C. van der Wal Stephan Windecker Mohamed Chettibi Hamlet Hayrapetyan Franz Xaver Roithinger Farid Aliyev Volha Sujayeva Marc J. Claeys Elnur Smajić Petr Kala Kasper Karmak Iversen Ehab E. El Hefny Toomas Marandi Pekka Porela Slobodan Antov Martine Gilard

Kristian Thygesen∗ (Denmark) Joseph S. Alpert∗ (USA) Allan Jaffe (USA) Bernard R. Chaitman (USA) Jeroen J. Bax (The Netherlands) David A. Morrow (USA) Harvey D. White∗ (New Zealand) Hans Mickley (Denmark) Filippo Crea (Italy) Frans Van de Werf (Belgium) Chiara Bucciarelli-Ducci (

10.1093/eurheartj/ehy462 article EN European Heart Journal 2018-08-25

10.1016/j.jacc.2005.10.065 article EN publisher-specific-oa Journal of the American College of Cardiology 2006-04-01

The purpose of this document is to make the output International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT) Standardization and Validation available medical scientific communities, through a peer-reviewed publication, in interest improving diagnosis treatment patients with atherosclerosis, including coronary artery disease. optical coherence tomography (IVOCT) catheter-based modality that acquires images at resolution ∼10 μm, enabling visualization blood vessel...

10.1016/j.jacc.2011.09.079 article EN cc-by-nc-nd Journal of the American College of Cardiology 2012-03-01

Background— The US Food and Drug Administration recently issued a warning of subacute thrombosis hypersensitivity reactions to sirolimus-eluting stents (Cypher). cause incidence these events have not been determined. Methods Results— We present findings 58-year-old man who died late stent 18 months after receiving 2 Cypher for unstable angina. Although angiographic intravascular ultrasound results at 8 demonstrated the absence neointimal formation, vessel enlargement was present. An autopsy...

10.1161/01.cir.0000116202.41966.d4 article EN Circulation 2004-01-27

Heart failure can result from a variety of causes, including ischemic, hypertensive, toxic, and inflammatory heart disease. However, the cellular mechanisms responsible for progressive deterioration myocardial function observed in remain unclear may apoptosis (programmed cell death).We examined seven explanted hearts obtained during cardiac transplantation evidence apoptosis. All patients had severe chronic failure: four idiopathic dilated cardiomyopathy, three ischemic cardiomyopathy. DNA...

10.1056/nejm199610173351603 article EN New England Journal of Medicine 1996-10-17

Intraplaque hemorrhage is common in advanced coronary atherosclerotic lesions. The relation between and the vulnerability of plaque to disruption may involve accumulation free cholesterol from erythrocyte membranes.

10.1056/nejmoa035655 article EN New England Journal of Medicine 2003-12-11

Background— Late stent thrombosis (LST) after Cypher and Taxus drug-eluting placement has emerged as a major concern. Although the clinical predictors of LST have been reported, specific morphological histological correlates remain unknown. Methods Results— From registry totaling 81 human autopsies stents, 46 (62 lesions) had implanted >30 days. We identified 28 lesions with thrombus compared those 34 similar duration without using computer-guided morphometric analyses. was defined an...

10.1161/circulationaha.107.693739 article EN Circulation 2007-04-17

Background —Subclinical episodes of plaque disruption followed by healing are considered a mechanism increased burden. Detailed pathological studies healed ruptures, however, lacking. Methods and Results —We identified acute ruptures from 142 men who died sudden coronary death performed morphometric measurements burden, luminal stenosis, smooth muscle cell phenotype. Healed were found in 61% hearts associated with myocardial infarction, heart weight, dyslipidemia, diabetes. Multiple rupture...

10.1161/01.cir.103.7.934 article EN Circulation 2001-02-20
Coming Soon ...